Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Consensus Rating of "Hold" from Brokerages
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have earned a consensus rating of "Hold" from the eighteen research firms that are covering the stock, MarketBeat reports. Three...